Prediction Case File
YouTubeTracking Live

Meta Stock's Rally Is JUST Getting Started!

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
21 Oct 2026, 21:23 UTC
Recorded by Tahlil Plus
21 Oct 2026, 22:18 UTC
Video preview for Meta Stock's Rally Is JUST Getting Started!
Source overview

AI-generated source summary

Meta's Q3 2023 earnings report revealed robust financial performance, exceeding analyst expectations. Revenue reached $64.60 billion, a 26% year-over-year increase, driven by strong performance across its platforms. Daily Active People (DAP) grew to 3.64 billion on average, a 3% year-over-year increase, indicating continued user engagement. Average Revenue Per Person (ARPP) also hit an all-time high of $17.72, showcasing effective monetization strategies. While capital expenditures are projected to be between $135 billion and $145 billion, this figure is in line with previous guidance and analyst expectations. The company's initiative to introduce new non-voting Class C shares aims to fund AI expansion without diluting Mark Zuckerberg's voting control. This move, similar to Google's historical strategy, is intended to provide flexibility in raising capital through stock issuance at favorable valuations while maintaining strategic control. The valuation model suggests a potential upside to $1221.30 based on a 15% EPS growth over the next five years and a forward P/E ratio of 20, indicating a bullish outlook for the stock. Despite some concerns about dilution, the company's ability to monetize its vast user base and invest in AI suggests strong long-term growth potential.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
359
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail